NCT00053092View on ClinicalTrials.gov

Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

February 28, 2009

Conditions
Lymphoma
Interventions
BIOLOGICAL

rituximab

DRUG

cyclophosphamide

DRUG

fludarabine phosphate

Trial Locations (2)

3002

Peter MacCallum Cancer Centre, East Melbourne

PL6 8DH

Derriford Hospital, Plymouth

All Listed Sponsors
collaborator

Australasian Leukaemia and Lymphoma Group

OTHER

lead

Institute of Cancer Research, United Kingdom

OTHER

NCT00053092 - Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma | Biotech Hunter | Biotech Hunter